IFNA1 and Dravet syndrome: Although these results support the notion that an interferonopathy underlies much of the pathophysiology of DS, the multiple impacts of IFN hyperactivity on the development, physiology, metabolism, clinical risk profiles, and accelerated aging of persons with DS await elucidation.